Skip to main content

Table 5 The correlation of CDK5 expression with various clinical pathological factors in SCLC

From: An immunohistochemical study of cyclin-dependent kinase 5 (CDK5) expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker

SCLC

n

CDK5 negative (n, %)

CDK5 positive (n, %)

Z

P

Gender

   

−2.089

0.037

 Male

21

11(52.4)

10(47.6 )

  

 Female

5

0(0)

5(100)

  

Age(years)

   

−0.515

0.606

 <60

15

7(46.7)

8(53.3)

  

 ≥60

11

4(36.4)

7(63.6)

  

TNM

   

−1.948

0.051

 I–II

13

8(61.5)

5(38.5)

  

 III–IV

10

2(20.0)

8(80.0)

  

LNM

   

−2.201

0.028

 Yes

13

3(23.1)

10(76.9)

  

 No

10

7(70.0)

3(30.0)

  

Tumor diameter (cm)

   

−1.888

0.059

 ≤7

19

10(52.6)

9(47.4)

  

 >7

 

0(0)

4(100)